Related Experiment Videos

Hormone resistance in prostate cancer

M J Pilat¹, J M Kamradt, K J Pienta

¹Department of Internal Medicine, University of Michigan, Ann Arbor, USA.

Cancer Metastasis Reviews

|August 24, 1999

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells.

Proceedings of the National Academy of Sciences of the United States of America·2021

Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy.

Seminars in cancer biology·2020

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer.

Medical oncology (Northwood, London, England)·2020

PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.

Prostate cancer and prostatic diseases·2016

A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors.

Investigational new drugs·2013

Detection of apoptosis in renal cell carcinoma.

Methods in molecular medicine·2011

See all related articles